Prescient Therapeutics Limited (ASX:PTX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0850
+0.0030 (3.66%)
Jul 31, 2026, 4:10 PM AEST

Prescient Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
4.274.363.712.431.891.19
Revenue Growth
-2.08%17.35%52.89%28.52%59.37%15.17%
Gross Profit
4.274.363.712.431.891.19
Operating Income
-8.91-7.54-7.19-7.46-5.21-4.24
Net Income
-8.86-7.32-8.24-7-5.12-4.15
Earnings Per Share
-0.01-0.01-0.01-0.01-0.01-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
9.776.9314.5121.9212.2816.12
Total Debt
0.27-0.33--0.17
Net Cash (Debt)
9.56.9314.1821.9212.2815.95
Net Cash Growth
37.09%-51.16%-35.28%78.41%-22.99%120.93%
Net Cash Per Share
0.010.010.020.030.020.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-8-7.24-7.4-6.19-4.31-3.97
Capital Expenditures
-----0-0
Free Cash Flow
-8-7.24-7.4-6.19-4.32-3.97
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-208.79%-172.98%-193.58%-307.14%-275.75%-357.80%
Pretax Margin
-207.71%-168.09%-221.91%-288.47%-270.85%-349.97%
Profit Margin
-207.71%-168.09%-221.91%-288.47%-270.85%-349.97%
FCF Margin
-187.48%-166.27%-199.28%-254.97%-228.50%-335.08%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-5.245.245.245.245.24
PS Ratio
20.958.138.2426.8653.68132.49